Evidence map›Paper›PMID 36335609›Full record

SynthesisClinical cardiology2022

The efficacy of nitroglycerin to prevent radial artery spasm and occlusion during and after transradial catheterization: A systematic review and meta-analysis of randomized controlled trials.

Basel Abdelazeem, Mohamed T Abuelazm, Sarya Swed, Mohamed Gamal, Mostafa Atef, Mohamed A Al-Zeftawy, Muhammad A Noori, Anthony Lutz, Annabelle S Volgman

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05626660 (Comparison Between Right and Left Radial Approach in Patients Undergoing Percutaneous Coronary Procedures), which is not on this map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05626660 completednot on this map

Comparison Between Right and Left Radial Approach in Patients Undergoing Percutaneous Coronary Procedures

TypeobservationalSponsorAssiut UniversityRan2022 to 2025Enrolled100ConditionsCoronary Artery DiseaseArmsCoronary angiography and percutaneous coronary intervention
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Precision percutaneous coronary intervention.NPJ cardiovascular health · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Basel AbdelazeemMcLaren Health Care, Flint, Michigan, USA.ORCID http://orcid.org/0000-0002-2919-6196
Mohamed T AbuelazmFaculty of Medicine, Tanta University, Tanta, Egypt.
Sarya SwedFaculty of Medicine, Aleppo University, Aleppo, Syria.ORCID http://orcid.org/0000-0002-9983-2020
Mohamed GamalFaculty of Medicine, Tanta University, Tanta, Egypt.ORCID http://orcid.org/0000-0001-5302-5349
Mostafa AtefFaculty of Medicine, Cairo University, Cairo, Egypt.
Mohamed A Al-ZeftawyFaculty of Medicine, Tanta University, Tanta, Egypt.
Muhammad A NooriRutgers Health/Trinitas, New Jersey, USA.
Anthony LutzMichigan State University, East Lansing, Michigan, USA.
Annabelle S VolgmanDivision of Cardiology, Rush University Medical Center, Chicago, Illinois, USA.
Tanta University · EGBotsford Hospital · USCairo University · EGMcLaren Health Care · USRush University Medical Center · USRutgers, The State University of New Jersey · USUniversity of Aleppo · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radial artery spasm (RAS) is the most common cause of transradial access site crossover and is a common intra-procedural complication. RAS incidence can lead to radial artery occlusion (RAO) postprocedure, preventing the radial artery as a future access site. We evaluated the efficacy of nitroglycerin preventing RAS and RAO during transradial catheterization discussing the different routes of administration, including topical, subcutaneous, and intra-arterial. A systematic review and meta-analysis included all relevant articles until April 23, 2022. We searched six databases Google Scholar, Web of Science, SCOPUS, EMBASE, PubMed (MEDLINE), and CENTRAL. We registered our review protocol in PROSPERO with ID: CRD42022330356. We included 11 trials with 5814 patients. Compared to placebo, the pooled analysis favored subcutaneous nitroglycerin in preventing RAS (risk ratio [RR]: 0.57 with 95% confidence interval [CI] [0.43-0.77], p = .0003) and RAO (RR: 0.39 with 95% CI [0.16-0.98], p = .05). In contrast to the intra-arterial nitroglycerin that showed nonstatistically significant results in preventing RAS and RAO (RR: 0.8 with 95% CI [0.63-1.02], p = .07)- (RR: 0.78 with 95% CI [0.6-1.01], p = .06)), respectively. Also, topical nitroglycerin did not prevent RAS (RR: 0.73 with 95% CI [0.42-1.24], p = .24). Compared with placebo, subcutaneous nitroglycerin during transradial catheterization reduced the incidence of RAS and RAO. Meanwhile, Intra-arterial and topical nitroglycerin did not show statistically significant outcomes. Subcutaneous nitroglycerin may be a practical and cost-effective technique to facilitate transradial catheterization; however, more RCTs are needed to evaluate the subcutaneous versus intra-arterial nitroglycerin administration.

Indexed as

Arterial Occlusive DiseasesNitroglycerinCardiac CatheterizationHumansRadial ArteryRandomized Controlled Trials as TopicSpasmVasodilator AgentsNitroglycerinVasodilator Agentscardiac interventionnitroglycerinradial artery occlusionradial artery spasmRAORAStransradial

Identifiers

PMID36335609
PMCPMC9748765
OpenAlexW4308286900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.